Skip to main content
Tech.euFundingExplorerBeta

Spotlight Pathology

Developing artificial intelligence software to streamline the diagnosis of blood cancers.

Spotlight Pathology has raised €2.1M across 2 funding rounds from 2 investors, most recently a Seed round in Mar 2026. Based in Manchester, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€2.1M
€2,120,008
Funding rounds
2
Investors
2
distinct backers
Active since
2025-04
latest 2026-03

Funding by year

EUR raised per year · 2026 YTD
Spotlight Pathology — funding by year — interactive chart.
Data table
Spotlight Pathology — funding by year
2025€499k
2026€1.6M

Signals

High confidence
Raise-next likelihood52
base rate 44% for Seed
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-03-11Seed€1.6MUK Innovation and Science Seed Fund (UKI2S)View deal →
2025-04-30Other€499kEHE VenturesView deal →

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData